ESTRING
Drug
PFIZER INC.
Total Payments
$200,439
Transactions
3,261
Doctors
2,166
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $990.58 | 52 | 50 |
| 2023 | $144,937 | 73 | 60 |
| 2022 | $182.28 | 12 | 12 |
| 2021 | $182.44 | 12 | 11 |
| 2020 | $141.18 | 8 | 8 |
| 2019 | $272.67 | 33 | 21 |
| 2018 | $135.66 | 15 | 13 |
| 2017 | $53,598 | 3,056 | 2,025 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $151,122 | 11 | 75.4% |
| Food and Beverage | $40,070 | 3,247 | 20.0% |
| Unspecified | $8,830 | 2 | 4.4% |
| Travel and Lodging | $417.96 | 1 | 0.2% |
Payments by Type
General
$191,610
3,259 transactions
Research
$8,830
2 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A RANDOMIZED CONTROLLED TRIAL OF VAGINAL ESTROGEN TO TREAT ASYMPTOMATIC MICROSCOPIC HEMATURIA | PFIZER INC. | $8,830 | 0 |
Top Doctors Receiving Payments for ESTRING
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Obstetrics & Gynecology | New York, NY | $127,188 | 6 |
| , M.D | Gynecologic Oncology | Denver, CO | $16,585 | 3 |
| Unknown | — | Cambridge, MA | $8,830 | 2 |
| , M.D., FACOG | Obstetrics & Gynecology | New Haven, CT | $5,278 | 3 |
| , MD | Obstetrics & Gynecology | Poughkeepsie, NY | $2,607 | 2 |
| , M.D | Gynecology | New Haven, CT | $153.51 | 4 |
| , MD | Obstetrics & Gynecology | Wichita, KS | $128.43 | 6 |
| , MD | Obstetrics & Gynecology | Wichita, KS | $128.43 | 6 |
| , M.D | Urology | Fulton, NY | $123.35 | 5 |
| , MD | Obstetrics & Gynecology | Wichita, KS | $118.93 | 5 |
| , MD | Urology | Fulton, NY | $118.89 | 5 |
| , MD | Reproductive Endocrinology | New Haven, CT | $117.34 | 2 |
| , MD | Obstetrics & Gynecology | Wallingford, CT | $112.84 | 1 |
| , MD | Obstetrics & Gynecology | Meriden, CT | $112.84 | 1 |
| , MD | Obstetrics & Gynecology | East Syracuse, NY | $100.81 | 1 |
| , MD | Gynecology | Kenmore, NY | $93.91 | 8 |
| , M.D | Obstetrics & Gynecology | Zephyrhills, FL | $84.97 | 3 |
| , MD | Gynecology | Lakeland, FL | $84.84 | 1 |
| , MD | Gynecology | Lakeland, FL | $84.84 | 1 |
| , M.D | Obstetrics & Gynecology | Fayetteville, NC | $81.89 | 2 |
| , M.D | Obstetrics & Gynecology | Pinehurst, NC | $81.74 | 2 |
| , MD | Specialist | Pinehurst, NC | $81.74 | 2 |
| , M.D | Obstetrics & Gynecology | Pinehurst, NC | $81.74 | 2 |
| , M.D | Obstetrics & Gynecology | West Lake Hills, TX | $80.61 | 5 |
| , MD | Obstetrics & Gynecology | Southern Pines, NC | $79.64 | 2 |
Ad
Manufacturing Companies
- PFIZER INC. $200,343
- HOSPIRA, INC. $96.66
Product Information
- Type Drug
- Total Payments $200,439
- Total Doctors 2,166
- Transactions 3,261
About ESTRING
ESTRING is a drug associated with $200,439 in payments to 2,166 healthcare providers, recorded across 3,261 transactions in the CMS Open Payments database. The primary manufacturer is PFIZER INC..
Payment data is available from 2017 to 2024. In 2024, $990.58 was paid across 52 transactions to 50 doctors.
The most common payment nature for ESTRING is "Consulting Fee" ($151,122, 75.4% of total).
ESTRING is associated with 1 research study, including "A RANDOMIZED CONTROLLED TRIAL OF VAGINAL ESTROGEN TO TREAT ASYMPTOMATIC MICROSCOPIC HEMATURIA" ($8,830).